Titre : Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group
link : Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group
Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group
By Susan Decker and Cynthia Koons
October 25, 2017 8:01 AM EDT
October 25, 2017 8:01 AM EDT
Group says patents have blocked access to life-saving medicine
Pricey hepatitis C treatment has been a top seller for Gilead
Gilead Sciences Inc.’s U.S. patents on the blockbuster $84,000 hepatitis C treatment Sovaldi were challenged by a consumer group that’s battled the drugmaker around the world over the pricing.
The Initiative for Medicines, Access & Knowledge, a nonprofit focused on how patents affect access to medicine, said that it’s filed petitions with the U.S. Patent Trial and Appeal Board seeking to challenge intellectual-property rights that would keep generic versions of Sovaldi from entering the market.
Read the article Bloomberg
Navigate This Blog
The controversy over expensive new drugs for hepatitis C
Link to research and news articles addressing the high cost of hepatitis C drugs; insurance restrictions - private insurers/Medicaid - and availability of generic versions/India, Egypt and other lower-income countries or through online "buyers clubs"
The Initiative for Medicines, Access & Knowledge, a nonprofit focused on how patents affect access to medicine, said that it’s filed petitions with the U.S. Patent Trial and Appeal Board seeking to challenge intellectual-property rights that would keep generic versions of Sovaldi from entering the market.
Read the article Bloomberg
Navigate This Blog
The controversy over expensive new drugs for hepatitis C
Link to research and news articles addressing the high cost of hepatitis C drugs; insurance restrictions - private insurers/Medicaid - and availability of generic versions/India, Egypt and other lower-income countries or through online "buyers clubs"
Thus articles Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group
that is all articles Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group the link address https://newsaninpiration.blogspot.com/2017/10/gileads-patents-on-hepatitis-c-drug.html
0 Response to "Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group"
Post a Comment